Get started
Author

Neel Ketankumar Parikh

Observed name: Neel Parikh
OpenAlex ID: A5137229496
Efficacy and safety of immune checkpoint inhibitors in advanced non–small cell lung cancer: A systematic review and meta-analysis of randomized trials.
2026 · Gaurav Kansal, Shankar Biswas, et al. · Journal of Clinical Oncology
EGFR tyrosine kinase inhibitor plus angiogenesis inhibitor combination therapy in treatment-naïve EGFR -mutant advanced non–small cell lung cancer: A systematic review and meta-analysis.
2026 · Gaurav Kansal, Shankar Biswas, et al. · Journal of Clinical Oncology
PDF
Use of multi-omics biomarkers to predict benefit from immune checkpoint inhibitors in biliary tract cancers: A systematic review and meta-analysis.
2026 · Neel Parikh, Sannidhya Singh, et al. · Journal of Clinical Oncology
Comparative real-world outcomes with talquetamab and teclistamab in relapsed/refractory multiple myeloma: A TriNetX observational study.
2026 · Aneeq Mahmood Khan, Rubia Ali, et al. · Journal of Clinical Oncology
Comparative effectiveness of antibody-drug conjugates and targeted therapies in acute myeloid leukemia: A network meta-analysis of 15,412 patients.
2026 · Shankar Biswas, Gaurav Kansal, et al. · Journal of Clinical Oncology
Prognostic performance of Child-Pugh and MELD scores in critically ill patients with hepatocellular carcinoma: A MIMIC-IV cohort study.
2026 · Ayman Hamadttu, Shankar Biswas, et al. · Journal of Clinical Oncology
Inotuzumab ozogamicin versus blinatumomab in pediatric relapsed/refractory CD22-positive B-cell acute lymphoblastic leukemia: A systematic review and meta-analysis.
2026 · Neel Ketankumar Parikh, Bharat Parmar, et al. · Journal of Clinical Oncology
PDF
Translating meta-analytic risk into absolute survival: Projection modeling of secondary-type mutations in ELN-favorable NPM1-mutated acute myeloid leukemia.
2026 · Nimra Shafi, Madho Mal, et al. · Journal of Clinical Oncology
Mortality trends of lymphoid and hematopoietic malignancies among US adults: A CDC WONDER– based demographic and regional analysis, 1999–2020.
2026 · Muskan Asghar, Inza Saif, et al. · Journal of Clinical Oncology
From relative risk to lives lost: Meta-analysis–based projection of invasive fungal infection burden attributable to systemic corticosteroids.
2026 · Muhammad Hassan Khan, Madho Mal, et al. · Journal of Clinical Oncology
PDF
Comparative mortality burden of primary brain malignancies versus brain metastases in the United States.
2026 · Fnu Urooba, Shehdev Meghwar, et al. · Journal of Clinical Oncology
PDF
A silent but rising threat: Increasing small intestinal cancer mortality among older adults in the United States.
2026 · Fnu Urooba, Shehdev Meghwar, et al. · Journal of Clinical Oncology
Comparative effectiveness of ALK tyrosine kinase inhibitors in ALK-positive non–small cell lung cancer: A systematic review and network meta-analysis.
2026 · Yashasvi Srivastava, Shankar Biswas, et al. · Journal of Clinical Oncology
Concordance of EGFR and KRAS mutation status between primary non–small cell lung cancer and corresponding metastases: A systematic review and meta-analysis.
2026 · Rahul Falodia, Shankar Biswas, et al. · Journal of Clinical Oncology
Differential risk of interstitial lung disease with DXd-based versus non-DXd TROP2 antibody-drug conjugates: A systematic review and meta-analysis.
2026 · Prahlad Rao Kulkarni, Shankar Biswas, et al. · Journal of Clinical Oncology
Lymphoma histology as independent predictor of ICU mortality after adjustment for illness severity: A retrospective cohort study of 1,268 patients.
2026 · Prahlad Rao Kulkarni, Shankar Biswas, et al. · Journal of Clinical Oncology
Efficacy and safety of retifanlimab across solid tumors: A systematic review and meta-analysis.
2026 · Rahul Falodia, Shankar Biswas, et al. · Journal of Clinical Oncology
Temporal trends in intensive care unit outcomes for lung cancer patients: A 15-year analysis of the MIMIC-IV database.
2026 · Shankar Biswas, Yashasvi Srivastava, et al. · Journal of Clinical Oncology
Dual BRAF/MEK inhibition in BRAF V600E –mutated biliary tract cancer with exploratory histology-dependent response: A systematic review and meta-analysis.
2026 · Neel Parikh, Sannidhya Singh, et al. · Journal of Clinical Oncology
Progression-free survival as a surrogate endpoint for overall survival in metastatic triple-negative breast cancer: A systematic review and meta-analysis.
2026 · Yashasvi Srivastava, Shankar Biswas, et al. · Journal of Clinical Oncology
Comparative efficacy and safety of systemic therapies in high-risk hormone-sensitive prostate cancer: A network meta-analysis of 13 phase III randomized trials.
2026 · Neel Ketankumar Parikh, Anagha Shree, et al. · Journal of Clinical Oncology
Works count: 21
Citation count:
H-index:
I10-index:
Year
Topic
Type